跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Ashwagandha
首页
药物
Ashwagandha
Botanical Dietary Supplement
Ashwagandha
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
药物类型
botanical dietary supplement
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Compositions for alleviating inflammation and oxidative stress in a mammal
US 2005226942 A1
申请人: MYHILL PAUL R
优先权: 2005
CN
EP
US
14 件公开
US 9265808 B2
申请人: LIFELINE NUTRACEUTICALS CORP
优先权: 2013
US
3 件公开
PLANT BASED SUPPLEMENT COMPOSITIONS
EP 4595777 A3
申请人: THE GOOD KARMA COMPANY LLC
优先权: 2021
EP
US
5 件公开
Composition of ashwagandha and indian gooseberry
US 8206757 B2
申请人: MCNEARY PETER
优先权: 2009
US
4 件公开
Composition of beta-glucan and ashwagandha
US 8597697 B2
申请人: MCNEARY PETER S
优先权: 2012
US
4 件公开
FUNCTIONAL CHEWING GUM COMPRISING PHYTONUTRIENTS AND ADAPTOGENIC HERBS
EP 3672578 A1
申请人: BRILLIANTIQ AB
优先权: 2017
CN
EP
US
3 件公开
HAIR CARE NUTRITIONAL SUPPLEMENT COMPOSITION
EP 4201418 A1
申请人: ASC REGENITY LTD
优先权: 2021
EP
WO
3 件公开
COMPOSITION AND METHODS FOR ACTIVATING CELLULAR SIGNALING GENES IN INNATE INFLAMMATORY PATHWAYS
US 2024398693 A1
申请人: LIFEVANTAGE CORP
优先权: 2023
US
WO
3 件公开
US 20260165357 A1
申请人: LIFEVANTAGE CORP
优先权: 2025
US
Functional formulation in chewing gum
US 8636985 B2
申请人: BARRON JON
优先权: 2011
US
3 件公开
Process to enhance the bioactivity of Ashwagandha extracts
US 10251927 B2
申请人: ANTONY BENNY
优先权: 2015
US
3 件公开
US 12263201 B2
申请人: ARJUNA NATURAL PRIVATE LTD
优先权: 2023
US
2 件公开
US 9987323 B2
申请人: ANTONY BENNY
优先权: 2017
US
USE OF WITHANIA SOMNIFERA EXTRACT TO PROTECT AGAINST AIR POLLUTION RELATED DISEASES
EP 3615051 A1
申请人: DSM IP ASSETS BV
优先权: 2017
CN
EP
2 件公开
第 1 / 7 页
上一页
下一页
药物
反馈